Growth hormone secreting – immediate postoperative radiosurgery for residual





















Skull Base Region Sella turcica and right cavernous sinus
Histopathology Pituitary macroadenoma, immunoreactive for growth hormone
Prior Surgical Resection Yes
Pertinent Laboratory Findings GH: 2.23 ng/mL; IGF-1: 707 ng/mL; Prolactin 34.6 ng/mL


Case description


A 30-year-old female sought care after developing persistent galactorrhea following the birth of her first and second children. Preliminary lab work revealed normal prolactin levels but a high level of insulin-like growth factor 1 (IGF-1). Imaging was not sought until a year later when an MRI revealed a pituitary macroadenoma with right cavernous sinus invasion and compression of the optic chiasm ( Figure 3.14.1 ). At this time, her growth hormone (GH) was 2.23 ng/mL, IGF-1 was significantly elevated to 707 ng/mL, and prolactin was slightly elevated to 34.6 ng/mL. The patient reported significantly sharp daily headaches, polydipsia, and polyuria. Formal visual field testing did not reveal any deficits. The decision was made to pursue surgery, during which she underwent endonasal transsphenoidal resection, which was complicated by a cerebrospinal fluid leak that was repaired intraoperatively ( Figure 3.14.2 ). Surgical pathology revealed a pituitary macroadenoma that was immunoreactive for GH. At follow-up, the patient reported improved headaches, decreased frequency of nocturia, and reduced libido. A glucose tolerance test showed a near-normal GH response down to 0.51 ng/mL. However, considering the residual tumor and risk of recurrence, she was referred for Gamma Knife Radiosurgery (GKRS) ( Figure 3.14.3 ).














Radiosurgery Machine Gamma knife
Radiosurgery Dose (Gy) 25, at 50% isodose line
Number of Fractions 1



Figure 3.14.1.


Initial postcontrast T1-weighted image prior to transsphenoidal resection.



Figure 3.14.2.


Postoperative postcontrast T1-weighted image after transsphenoidal resection.



Figure 3.14.3.


Imaging of treatment plan.

























Critical Structure Dose Tolerance
Optic nerve/chiasm


  • 10 Gy maximum point dose



  • <0.2 cc >8 Gy

Brainstem


  • 15 Gy maximum point dose



  • <1 cc >10 Gy

Cranial nerves in cavernous sinus


  • Not fully defined but significantly more resistant than the anterior optic apparatus



  • Can be more sensitive if SRS follows another type of radiation therapy

Cavernous carotid artery


  • Very tolerant



  • Rare cases of asymptomatic carotid stenosis after SRS for pituitary adenomas have been reported

Normal pituitary gland and pituitary stalk Recommend limiting radiation exposure to the identifiable gland to <11.0 Gy and avoid whole-sella SRS whenever possible

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 6, 2024 | Posted by in GENERAL RADIOLOGY | Comments Off on Growth hormone secreting – immediate postoperative radiosurgery for residual

Full access? Get Clinical Tree

Get Clinical Tree app for offline access